Can I Take Ginseng with Vyleesi (Bremelanotide)?

What Vyleesi Does in the Body

Bremelanotide activates melanocortin-4 receptors (MC4R) in the central nervous system, which modulate sexual desire through dopaminergic and oxytocinergic pathways. The FDA approved it in June 2019 specifically for premenopausal women with acquired, generalized HSDD [1]. It is self-administered as a 1.75 mg subcutaneous injection at least 45 minutes before anticipated sexual activity, with a maximum of one dose per 24 hours and no more than eight doses per month.

Cardiovascular Profile of Bremelanotide

The prescribing label carries a warning about transient blood pressure increases. In the pooled RECONNECT phase 3 trials (N=1,247), bremelanotide produced a mean systolic increase of approximately 6 mmHg and a diastolic increase of roughly 3 mmHg, peaking about 2 to 4 hours post-injection and resolving within 12 hours [2]. Heart rate rose by a mean of 5 beats per minute. These changes led the FDA to contraindicate Vyleesi in patients with uncontrolled hypertension or known cardiovascular disease [1].

Metabolism and Clearance

Bremelanotide is not extensively metabolized by cytochrome P450 enzymes. It undergoes hydrolysis in body tissues, and renal excretion accounts for approximately 65% of clearance [1]. This metabolic profile means traditional drug-drug interactions mediated by CYP3A4, CYP2D6, or CYP2C19 are unlikely with most supplements, ginseng included.

How Ginseng Works and Why It Matters Here

Ginseng refers primarily to two species used medicinally: Panax ginseng (Asian or Korean ginseng) and Panax quinquefolius (American ginseng). The active constituents are ginsenosides, a family of steroidal saponins that number over 100 distinct compounds across both species [3]. These ginsenosides interact with multiple receptor systems, including nitric oxide synthase, estrogen receptors, and AMP-activated protein kinase.

Blood Pressure Effects of Ginseng

Data on ginseng and blood pressure are mixed. A 2016 Cochrane systematic review of Panax ginseng for hypertension found insufficient high-quality evidence to confirm or refute an antihypertensive benefit [4]. Some randomized trials in normotensive adults have actually reported small transient BP elevations of 2 to 5 mmHg after acute ginseng dosing, particularly with high-ginsenoside Korean red ginseng extracts [5]. A 2020 meta-analysis of nine RCTs (N=565) published in the Journal of Human Hypertension found no statistically significant change in systolic BP from Panax ginseng supplementation overall, but noted significant heterogeneity across preparations [6].

The clinical implication: ginseng's effect on blood pressure is preparation-dependent, dose-dependent, and unpredictable at the individual level.

Anticoagulant and Antiplatelet Activity

Panax ginseng has demonstrated antiplatelet effects in vitro. Ginsenoside Rg1 inhibits thromboxane A2 formation, and ginsenoside Rg3 has shown platelet aggregation inhibition in human platelet-rich plasma studies [7]. Case reports have linked American ginseng to reduced INR in patients on warfarin, suggesting a possible antagonistic interaction through induction of CYP enzymes or P-glycoprotein [8]. The Natural Medicines Comprehensive Database rates the ginseng-warfarin interaction as "moderate" with "good" evidence quality.

This anticoagulant dimension becomes relevant if a patient using Vyleesi also takes warfarin, apixaban, or rivaroxaban. Ginseng may shift anticoagulant levels in either direction, which complicates any protocol involving multiple agents.

Glucose-Lowering Properties

A 2014 systematic review of 16 RCTs (N=770) found that Panax ginseng reduced fasting blood glucose by a mean of 0.7 mmol/L compared to placebo [9]. American ginseng showed even larger effects in some acute postprandial glucose studies [10]. Bremelanotide itself has no established glucose-lowering effect, but patients on metformin or SGLT2 inhibitors alongside ginseng and Vyleesi may experience additive hypoglycemia risk that warrants awareness.

The Interaction: Pharmacodynamic, Not Pharmacokinetic

No published study has tested ginseng and bremelanotide together. No case report describes an adverse event from the combination. The concern is entirely extrapolated from overlapping pharmacodynamic profiles.

Why CYP-Mediated Interactions Are Unlikely

Bremelanotide bypasses hepatic CYP metabolism almost entirely [1]. Ginseng does show mild CYP3A4 and CYP2D6 modulating activity in some in vitro assays [11], but this is irrelevant when the co-administered drug is not a CYP substrate. There is no reason to expect ginseng to change bremelanotide blood levels or vice versa.

The Additive Blood Pressure Concern

This is the primary clinical worry. Vyleesi reliably raises systolic BP by ~6 mmHg. If a patient takes a high-dose Korean red ginseng extract that also raises BP by 3 to 5 mmHg, the combined transient elevation could reach 9 to 11 mmHg. For a healthy premenopausal woman with a baseline systolic of 118 mmHg, that produces a peak around 127 to 129 mmHg, which is clinically insignificant. For a woman with a baseline of 138 mmHg (stage 1 hypertension per 2017 ACC/AHA guidelines [12]), the peak could reach 147 to 149 mmHg, placing her in transient stage 2 territory.

A Risk-Stratification Approach

The risk depends on three variables: baseline blood pressure, ginseng preparation and dose, and timing of co-administration. A practical framework:

• Low risk: Baseline systolic <120 mmHg, standardized ginseng extract <400 mg/day, doses separated by 4+ hours. No special monitoring beyond a pre-injection BP check.
• Moderate risk: Baseline systolic 120 to 135 mmHg, or high-dose ginseng (>400 mg/day of a ginsenoside-rich extract), or doses taken within 2 hours of each other. Check BP before and 1 hour after Vyleesi injection.
• Higher risk: Baseline systolic >135 mmHg, concurrent antihypertensive use, or concurrent anticoagulant therapy with known ginseng sensitivity. Discuss with your prescriber before combining. The Vyleesi label already contraindicates use in uncontrolled hypertension [1].

Dose-Separation and Timing Strategy

Because the concern is pharmacodynamic rather than pharmacokinetic, the goal of dose separation is to avoid overlapping peak cardiovascular effects, not to prevent absorption interference.

Ginseng Pharmacokinetics

Ginsenoside Rb1, the most abundant ginsenoside in Panax ginseng, reaches peak plasma concentration approximately 4 to 6 hours after oral ingestion. Terminal half-life is roughly 14 to 16 hours in human pharmacokinetic studies [13]. This means cardiovascular effects from a morning ginseng dose are likely still present in the evening but at lower intensity.

Practical Timing

Take ginseng in the morning with breakfast. If Vyleesi is used in the evening (the most common use pattern), 8 to 12 hours will have elapsed, placing the ginseng well past its peak pharmacodynamic window. Avoid taking ginseng within 4 hours of a planned Vyleesi injection. If you use ginseng twice daily, skip the evening dose on days you plan to use Vyleesi.

Monitoring Recommendations

Self-monitoring is straightforward with an automated home blood pressure cuff.

Before Starting the Combination

Take five consecutive days of morning blood pressure readings to establish your baseline. The 2017 ACC/AHA hypertension guidelines define normal as systolic <120 mmHg and diastolic <80 mmHg [12]. Record your readings in a log or phone app.

On Days You Use Vyleesi

Check BP immediately before the injection. If systolic is >140 mmHg or diastolic is >90 mmHg, do not inject and contact your prescriber. Check again 1 to 2 hours after the injection. If the systolic increase exceeds 15 mmHg from your pre-injection reading, note it for your next medical visit. Symptoms like severe headache, visual changes, or chest discomfort after injection require immediate medical attention regardless of BP readings.

Lab Monitoring

If you take anticoagulants, check INR or anti-Xa levels 2 weeks after adding ginseng and again 2 weeks after any dose change. If you take diabetes medications, monitor fasting glucose more frequently for the first 4 weeks of ginseng use, watching for readings below 70 mg/dL [9].

What To Do If You Are Already Taking Both

Many women discover the potential interaction after they have already been combining ginseng and Vyleesi without problems. That absence of adverse events is informative. Do not abruptly discontinue either agent in a panic.

Step-by-Step Approach

First, check your blood pressure at home over 3 days, ideally including a day you use Vyleesi. Second, review the specific ginseng product you take: check the label for ginsenoside content and daily dose. Third, mention both agents to your prescriber at your next visit. Bring the ginseng product label. Fourth, if your BP readings are consistently normal (systolic <130, diastolic <80) on combination days, no change is likely necessary. Fifth, if BP readings are borderline or elevated, implement the dose-separation strategy described above and recheck over 2 weeks.

Special Populations and Additional Considerations

Women on Antihypertensives

The Vyleesi label notes that bremelanotide slowed the oral absorption of the antihypertensive indomethacin in a drug interaction study, though clinical significance was minimal [1]. Adding ginseng as a third variable increases monitoring complexity. These patients should discuss the combination with their cardiologist or internist, not manage it independently.

Women on Hormonal Contraceptives

Some in vitro data suggest ginsenosides have weak estrogenic activity [14]. The clinical relevance to contraceptive efficacy is unproven, but the theoretical concern exists. Bremelanotide did not alter ethinyl estradiol or levonorgestrel pharmacokinetics in a dedicated interaction study [1], so the Vyleesi side of this equation is clean.

Women with Diabetes or Prediabetes

Ginseng's glucose-lowering effect is modest but real in meta-analyses [9]. If you use metformin or an SGLT2 inhibitor alongside ginseng and Vyleesi, the cardiovascular and metabolic monitoring burden increases. A CGM (continuous glucose monitor) can simplify glucose tracking if you fall into this category.

Ginseng Product Quality: A Practical Problem

Ginseng supplements are poorly regulated compared to prescription drugs. A 2015 analysis published in BMC Complementary Medicine found that ginsenoside content varied by up to 15-fold across 28 commercially available products, and several contained contaminants including pesticides and heavy metals [15]. If you choose to use ginseng alongside Vyleesi, select a product with independent third-party testing (USP Verified, NSF Certified for Sport, or ConsumerLab-approved) and a standardized ginsenoside content.

The dose used in most clinical trials of Panax ginseng is 200 to 400 mg of extract standardized to 4% to 7% ginsenosides, taken once or twice daily [3].